Amerikanische Gesellschaft für Hirudotherapie

Expression and function of an even-skipped homolog in the leech Helobdella robusta

Developmental biology published in Development (2002)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomik & ProteomikSong MH et al. · Development (Cambridge, England), 2002

Abstract

We have identified homologs of the Drosophila pair-rule gene even-skipped in the glossiphoniid leeches Helobdella robusta and Theromyzon trizonare. In leech embryos, segments arise sequentially from five pairs of embryonic stem cells (teloblasts) that undergo iterated divisions to generate columns (bandlets) of segmental founder cells (primary blast cells), which in turn generate segmentally iterated sets of definitive progeny. In situ hybridization revealed that Hro-eve is expressed in the teloblasts and primary blast cells, and that these transcripts appear to be associated with mitotic chromatin. In more advanced embryos, Hro-eve is expressed in segmentally iterated sets of cells in the ventral nerve cord. Lineage analysis revealed that neurons expressing Hro-eve arise from the N teloblast. To assess the function of Hro-eve, we examined embryos in which selected blastomeres had been injected with antisense Hro-eve morpholino oligonucleotide (AS-Hro-eve MO), concentrating on the primary neurogenic (N teloblast) lineage. Injection of AS-Hro-eve MO perturbed the normal patterns of teloblast and blast cell divisions and disrupted gangliogenesis. These results suggest that Hro-eve is important in regulating early cell divisions through early segmentation, and that it also plays a role in neuronal differentiation.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, U.S. Gov't, P.H.S.
Indexed MeSH termsAmino Acid SequenceAnimalsBody PatterningCell Cycle ProteinsCell DifferentiationCell DivisionCell LineageChromatinGenes, HomeoboxHomeodomain ProteinsHumansIn Situ Hybridization

Zusammenfassung

Hro-eve, a Drosophila even-skipped homolog, regulates teloblast and blast-cell divisions and ventral nerve cord neuron differentiation in the leech Helobdella robusta — providing evolutionary insight into segmentation gene networks.

Warum dies für die Hirudotherapie relevant ist

This study identified and characterized homologs of the Drosophila pair-rule gene even-skipped (Hro-eve) in the glossiphoniid leech Helobdella robusta, examining its expression in teloblasts, primary blast cells, and ventral nerve cord neurons, and its function through morpholino knockdown experiments. The abstract describes how antisense Hro-eve morpholino injection perturbed teloblast and blast cell divisions and disrupted gangliogenesis, suggesting roles in early cell division, segmentation, and neuronal differentiation. This is a developmental genetics study with no relevance to hirudotherapy, the leech secretome, or any therapeutic application of leeches or leech-derived compounds. The leech is used purely as a model organism for studying body patterning and developmental biology; the study does not address anticoagulants, salivary components, or any topic within ASH's domain.

Zitation

Expression and function of an even-skipped homolog in the leech Helobdella robusta.

Song MH et al. · Development (Cambridge, England), 2002

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.